China CAS NO 874638-80-9 Factory

Our products are extensively identified and reliable by consumers and will satisfy constantly developing economic and social desires for CAS NO 874638-80-9,874638-80-9,Sofosbuvir intermediate,Sofosbuvir advance intermediate,((2R,3R,4R)-3-(benzoyloxy), Special emphasis around the packaging of merchandise to avoid any damage during transportation,Detailed interest into the useful feedback and strategies of our esteemed shoppers.
CAS NO 874638-80-9, You can let us know your idea to develop unique design for your own model to prevent too much similar parts in the market! We are going to give our best service to satisfy all your needs! Remember to contact us right away!

Hot Products

  • (S)-2-CHLORO-1-PHENYL-ETHANOL

    (S)-2-CHLORO-1-PHENYL-ETHANOL

    Product Name:(S)-2-CHLORO-1-PHENYL-ETHANOL
    Molecular Formula:C8H9ClO
    Molecular Weight:156.61
    CAS Registry Number:70111-05-6
  • Molnupiravir

    Molnupiravir

    Product Name:Molnupiravir
    Molecular Formula:C13H19N3O7
    Molecular Weight;329.31
    CAS Registry Number;2349386-89-4
  • Betadex Sulfobutyl Ether Sodium

    Betadex Sulfobutyl Ether Sodium

    Product Name:Betadex Sulfobutyl Ether Sodium
    Molecular Formula:C42H70O35
    Molecular Weight:1134.9842
    CAS Registry Number:182410-00-0
  • Azacytidine

    Azacytidine

    Product Name:Azacytidine
    Molecular Formula:C8H12N4O5
    Molecular Weight;244.2
    CAS Registry Number;320-67-2
  • (9,9-Dimethyl-9H-fluoren-2,7-diyl)diboronic acid

    (9,9-Dimethyl-9H-fluoren-2,7-diyl)diboronic acid

    Product Name:(9,9-Dimethyl-9H-fluoren-2,7-diyl)diboronic acid
    Molecular Formula:C15H16B2O4
    Molecular Weight:281.91
    CAS Registry Number:866100-14-3
  • Cefepime hydrochloride

    Cefepime hydrochloride

    Product Name:Cefepime hydrochloride
    Molecular Formula:C19H28Cl2N6O6S2
    Molecular Weight;571.49
    CAS Registry Number;123171-59-5

Send Inquiry

X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept